Table 1 Patient demographics and outcomes for the total cohort and stratified by liver injury severity

Age

10.5 (6.8; 14.1)

10.9 (6.8; 14.2)

10.0 (7.1; 13.1)

0.67

Male gender

43 (65.2)

32 (65.3)

11 (64.7)

0.96

Blunt injury

64 (97.0)

47 (95.9)

17 (100)

1.00

ISS

20.5 (10.0; 33.0)

17.0 (9.0; 28.0)

25.0 (17.0; 34.0)

0.02

GCS

15.0 (14.0; 15.0)

15.0 (14.0; 15.0)

15.0 (15.0; 15.0)

0.16

Base excess^a

−2.1 (−4.9; −1.1)

−2.4 (−4.7; −0.9)

−2.0 (−5.3; −1.4)

0.96

Lactate^b

2.2 (1.3; 2.9)

2.3 (1.3; 2.9)

1.8 (1.4; 2.9)

0.55

Aspartate transaminase^c

302.5 (161.3; 521.0)

261.0 (145.0; 357.0)

618.0 (416.5; 969.0)

<0.01

Alanine transaminase^d

220.0 (120.0; 390.0)

189.5 (110.8; 266.5)

461.0 (355.0; 723.0)

<0.01

Positive abdominal findings

45 (68.2)

29 (59.2)

16 (94.1)

0.01

Attempted NOM

60 (90.9)

45 (91.8)

15 (88.2)

0.64

Angiographic embolization

2 (3.0)

0 (0.0)

2 (11.8)

0.06

Patients transfused

14 (21.2)

10 (20.4)

4 (23.5)

0.74

ICU LOS

2.0 (1.0; 5.0)

2.0 (1.0; 5.0)

2.0 (1.5; 7.0)

0.84

In-hospital LOS

7.0 (5.0; 11.3)

6.0 (5.0; 11.5)

7.0 (6.0; 13.0)

0.18

Mortality

2 (3.0)

1 (2.0)

1 (5.9)

0.45